Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 615 clinical trials
Remote Time Restricted Eating Delivery As A Primary Cancer Prevention Intervention (READY)  

This study will evaluate the implementation and effectiveness of free-living TRE on biological and behavioural breast cancer risk factors.

Accepts healthy volunteers
  • 0 views
  • 13 Jul, 2022
  • 1 location
A Randomized, Double-blind, Positive-drug Parallel Controlled, Multicenter Phase III Trial of the Efficacy and Safety of S086 Tablets in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)  

A randomized, double-blind, positive-drug parallel controlled, multicenter phase III trial of the efficacy and safety of S086 tablets in patients with chronic heart failure with reduced ejection fraction (HFrEF)

  • 0 views
  • 26 Sep, 2022
  • 5 locations
testing  

testing

  • 0 views
  • 24 Nov, 2022
  • 1 location
  • 0 views
  • 04 Aug, 2023
  • 1 location
AutoRun014775  

AutomationRun014775

  • 0 views
  • 22 Dec, 2022
  • 2 locations
AutoRun12082  

AutomationRun12082

  • 0 views
  • 07 Sep, 2023
  • 1 location
  • 0 views
  • 18 Nov, 2024
  • 1 location
Different Modalities of Management of Odontogenic Keratocysts (OKCs)  

Background The odontogenic keratocysts (OKCs) have been one of the maxillofacial region's most contentious pathological phenomena. Decompression/marsupialization (D/M), enucleation (E), enucleation + chemical cauterization with Carnoy's solution (E+CS), enucleation + peripheral ostectomy (E + PO), as opposed to enucleation + chemical cauterization with Carnoy's solution + peripheral ostectomy (E + …

  • 0 views
  • 30 Nov, 2023
  • 2 locations
A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients.  

To study the safety and toxicity of intranasal peptide T (D-Ala-1-peptide-T-amide) in humans, and to find out how quickly and how much of a given dose enters the bloodstream and how quickly it leaves the bloodstream. To obtain information on the ability of intranasal peptide T to prevent, halt, and/or …

  • 0 views
  • 16 Jul, 2025
  • 3 locations
MagnetisMM-20 Enrolling people with Multiple Myeloma  

A clinical trial to learn about the effects of combined treatments for multiple myeloma that has returned or not responded to previous treatment 

  • 0 views
  • 21 Jan, 2025
  • 2 locations